References
1. Microecology: fundamental and practical problems: Monograph. In: N.N. Pluzhnikov, J.A. Nakatis, O.G. Khurtsilava. Saint Petersburg: Izdatel’stvo SZGMU im. I.I. Mechnikova, 2012: 304 p. (in Russian)
2. Derrien M., Veiga P. Rethinking diet to aid human-microbe symbiosis. Trends Microbiol. 2017; 25 (2): 100-12.
3. Kornienko E.A. Current understanding of the relationship between obesity and intestinal microbiota. Pediatr [Pediatrician]. 2013; 4 (3): 3-14. (in Russian)
4. Drapkina O.M., Kaburova A.N. Intestinal microbiota - a new satellite on the route of cardiovascular diseases: unexpected roles of old neighbors. Ratsional’naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2016. 12 (1): 66-71. (in Russian)
5. Lambertz J., Weiskirchen S., Landert S., Weiskirchen R. Fructose: a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease. Front Immunol. 2017; 8: 1159.
6. Etxeberria U., Arias N., Boque N., et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem. 2015; 26 (6): 651-60.
7. Carrera-Quintanar L., López Roa R.I., Quintero-Fabián S., et al. Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases. Mediators Inflamm. 2018; 2018: 9734845.
8. Wang P., Li D., Ke W., et al. Resveratrol-induced gut microbiota reduced obesity in high-fat diet-fed mice. Int. J. Obes. (Lond.). 2019 Febr. doi: 10.1038/s41366-019-0332-1
9. Braune A., Blaut M. Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes. 2016; 7 (3): 216-34.
10. Rowland I., Gibson G., Heinken A., et al. Gut microbiota function: metabolism of nutrients and other food components. Eur J Nutr. 2018; 57 (1): 1-24.
11. Aksenov I.V., Avren’eva L.I., Guseva G.V., et al. Effects of quercetin on protective capacity in rats fed a high fructose diet. Voprosy pitaniia [Problems of Nutrition]. 2018; 87 (5): 6-12. (in Russian)
12. Djouzi Z., Andrieux C., Degivry M.C., et al. The association of yogurt starters with Lactobacillus casei DN 114001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats. J Nutr. 1997; 127 (11): 2260‑6.
13. Fotschki B., Juskiewicz J., Kolodziejczyk K., et al. Protective effects of ellagitannin-rich strawberry extracts on biochemical and metabolic disturbances in rats fed a diet high in fructose. Nutrients. 2018; 10 (4): pii: E445.
14. Jegatheesan P., Beutheu S., Ventura G., et al. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clin Nutr. 2016; 35 (1): 175-82.
15. Zubiria M.G., Gambaro S.E., Rey M.A., et al. Deleterious metabolic effects of high fructose intake: the preventive effect of Lactobacillus kefiri administration. Nutrients. 2017; 9 (5): pii: E470.
16. Vazquez Prieto M.A., Bettaieb A., Rodriguez Lanzi C., et al. Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes. Mol Nutr Food Res. 2015; 59 (4): 622-33.
17. Owis A.I., Abo-Youssef A.M., Osman A.H. Leaves of Cordia boissieri A. DC. as a potential source of bioactive secondary metabolites for protection against metabolic syndrome-induced in rats. Z Naturforsch C. 2017: 72 (3-4): 107-18.
18. Zhao Y., Chen B., Shen J., et al. The beneficial effects of quercetin, curcumin, and resveratrol in obesity. Oxid Med Cell Longev. 2017; 2017: 1459497.
19. Nikitin N.S., Kuznetsov S.P. Effect of quercetin on morphological changes in nonalcoholic fatty liver disease in high fructose-fed rats. Voprosy pitaniia [Problems of Nutrition]. 2018; 87 (6): 16-21. (in Russian)
20. Zhao L., Zhang Q., Ma W., et al. A combination of quercetin and resveratrol reduces obesity in high‑fat diet-fed rats by modulation of gut microbiota. Food Funct. 2017; 8 (12): 4644‑56.
21. Porras D., Nistal E., Martinez-Florez S., et al. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalans and related gut-liver axis activation. Free Radic Biol Med. 2017; 102: 188-202.
22. Grzelak-Blaszczyk K., Milala J., Cosmala M., et al. Onion quercetin monoglycosides alter microbial activity and increase antioxidant capacity. J Nutr Biochem. 2018; 56: 81-8.
23. QiaoY., Sun J., Xia S., et al. Effects of resveratrol on gut microbiota and fat storage in mouse model with high-fat-induced obesity. Food Fuct. 2014; 5 (6): 1241-9.
24. Bird J.K., Raederstorff D., Weber P., Steinert R.E. Cardiovascular and antiobesity effects of resveratrol mediated through the gut microbiota. Adv Nutr. 2017; 8 (6): 839-49.